We are live on ! Find out more
ACGA

Atlanta Consulting Group Advisors Portfolio holdings

AUM $465M
1-Year Est. Return 17.21%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+17.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$464M
AUM Growth
+$175M
Cap. Flow
+$172M
Cap. Flow %
37.04%
Top 10 Hldgs %
72.55%
Holding
141
New
10
Increased
36
Reduced
21
Closed
26

Sector Composition

Rank Sector Weight
1 Financials 9.09%
2 Technology 4.48%
3 Consumer Staples 2.93%
4 Consumer Discretionary 2.37%
5 Industrials 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
101
Boston Scientific
BSX
$71.5B
$246K 0.05%
3,200
XLY icon
102
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$244K 0.05%
+2,678
New +$238K
INTC icon
103
Intel
INTC
$513B
$242K 0.05%
7,825
-2,382
-23% -$78.1K
CMI icon
104
Cummins
CMI
$88.7B
$235K 0.05%
850
-20
-2% -$5.72K
MDT icon
105
Medtronic
MDT
$112B
$235K 0.05%
2,983
IYJ icon
106
iShares US Industrials ETF
IYJ
$2.02B
$229K 0.05%
+1,916
New +$233K
META icon
107
Meta Platforms (Facebook)
META
$1.51T
$221K 0.05%
438
BA icon
108
Boeing
BA
$185B
$215K 0.05%
1,180
BN icon
109
Brookfield
BN
$108B
$210K 0.05%
7,593
TSM icon
110
TSMC
TSM
$2.18T
$210K 0.05%
+1,209
New +$183K
VTV icon
111
Vanguard Morningstar Value ETF
VTV
$191B
$206K 0.04%
1,286
VRTX icon
112
Vertex Pharmaceuticals
VRTX
$126B
$205K 0.04%
+438
New +$190K
XLK icon
113
State Street Technology Select Sector SPDR ETF
XLK
$124B
$204K 0.04%
1,800
-446
-20% -$47K
IDEV icon
114
iShares Core MSCI International Developed Markets ETF
IDEV
$32.6B
$201K 0.04%
+3,058
New +$203K
AMRX icon
115
Amneal Pharmaceuticals
AMRX
$5.79B
$63.5K 0.01%
10,000
ACGL icon
116
Arch Capital
ACGL
$33.6B
-2,518
Closed -$233K
ACN icon
117
Accenture
ACN
$108B
-701
Closed -$243K
AON icon
118
Aon
AON
$76B
-775
Closed -$259K
ARCC icon
119
Ares Capital
ARCC
$14.4B
-11,490
Closed -$239K
ARLP icon
120
Alliance Resource Partners
ARLP
$3.17B
-1,175,428
Closed -$23.6M
ASML icon
121
ASML
ASML
$669B
-393
Closed -$381K
AZN icon
122
AstraZeneca
AZN
$250B
-1,658
Closed -$225K
CVS icon
123
CVS Health
CVS
$122B
-4,129
Closed -$329K
EL icon
124
Estee Lauder
EL
$32B
-1,775
Closed -$274K
EPD icon
125
Enterprise Products Partners
EPD
$81.7B
-22,097
Closed -$645K

Similar funds

Atlanta Consulting Group Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Atlanta Consulting Group Advisors held 141 positions worth $464M, up 60% from $289M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Atlanta Consulting Group Advisors deployed $172M of net new capital in Q2 2024, opening 10 new positions and adding to 36 existing holdings. Its largest new stake was Global X S&P 500 Catholic Values ETF: 76,308 shares worth $4.99M.

By sector, the portfolio is most concentrated in Financials at 9.1% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Novo Nordisk, an estimated $281K trimmed.

  • Atlanta Consulting Group Advisors's largest Q2 2024 buy was Global X S&P 500 Catholic Values ETF: 76,308 shares worth $4.99M.
  • Atlanta Consulting Group Advisors added most to iShares Core S&P Small-Cap ETF in Q2 2024, an estimated $47.4M increase.
  • Atlanta Consulting Group Advisors's biggest Q2 2024 reduction was Novo Nordisk, cutting an estimated $281K.
  • Atlanta Consulting Group Advisors fully exited Alliance Resource Partners in Q2 2024, selling an estimated $23.6M.
  • Atlanta Consulting Group Advisors's ten largest holdings make up 73% of its $464M portfolio in Q2 2024.
  • Atlanta Consulting Group Advisors opened 10 new positions and closed 26 in Q2 2024.
  • Atlanta Consulting Group Advisors's portfolio value rose 60% quarter-over-quarter to $464M.

Based on Atlanta Consulting Group Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.